Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limitedverified

SUNPHARMA.NS

Price:

$1744.9

Market Cap:

$4.19T

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, suc...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

1996-01-01

Stock Exchange

NSE

Ticker

SUNPHARMA.NS

The PE Ratio as of December 2025 (TTM) for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) is 40.00

According to Sun Pharmaceutical Industries Limited’s latest financial reports and current stock price. The company's current PE Ratio is 40.00. This represents a change of -0.57% compared to the average of 40.23 of the last 4 quarters.

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) Historical PE Ratio (quarterly & annually)

How has SUNPHARMA.NS PE Ratio performed in the past?

The mean historical PE Ratio of Sun Pharmaceutical Industries Limited over the last ten years is 40.99. The current 40.00 PE Ratio has changed 9.66% with respect to the historical average. Over the past ten years (40 quarters), SUNPHARMA.NS's PE Ratio was at its highest in in the December 2017 quarter at 94.25. The PE Ratio was at its lowest in in the September 2018 quarter at -174.37.

Quarterly (TTM)
Annual

Average

40.99

Median

41.33

Minimum

22.45

Maximum

67.06

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sun Pharmaceutical Industries Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 137.38%

Maximum Annual PE Ratio = 67.06

Minimum Annual Increase = -58.49%

Minimum Annual PE Ratio = 22.45

Quarterly (TTM)
Annual
YearPE RatioChange
202537.24-8.76%
202440.8246.64%
202327.84-58.49%
202267.0635.77%
202149.39120.00%
202022.45-47.91%
201943.10-23.53%
201856.37137.38%
201723.75-43.25%
201641.84-22.87%

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) Average PE Ratio

How has SUNPHARMA.NS PE Ratio performed in the past?

The current PE Ratio of Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

35.30

5-year avg

44.47

10-year avg

40.99

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) PE Ratio vs. Peers

How is SUNPHARMA.NS’s PE Ratio compared to its peers?

Sun Pharmaceutical Industries Limited’s PE Ratio is less than Divi's Laboratories Limited (69.21), less than Divi's Laboratories Limited (69.21), greater than Alkem Laboratories Limited (28.13), greater than Alkem Laboratories Limited (28.13), less than Ipca Laboratories Limited (43.45), greater than Lupin Limited (22.45), less than Ipca Laboratories Limited (43.45), less than Torrent Pharmaceuticals Limited (60.14), less than Torrent Pharmaceuticals Limited (60.14), less than Mankind Pharma Limited (51.21),

Build a custom stock screener for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sun Pharmaceutical Industries Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sun Pharmaceutical Industries Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Sun Pharmaceutical Industries Limited's PE Ratio?

How is the PE Ratio calculated for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)?

What is the highest PE Ratio for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)?

What is the 3-year average PE Ratio for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)?

What is the 5-year average PE Ratio for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)?

How does the current PE Ratio for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) compare to its historical average?